We first evaluated the expression profiles of HNF1B across 31 cancer types using RNA-seq data of The Cancer Genome Atlas (TCGA) and found that HNF1B was highly expressed in approximately top 25% of cancer types including PCa (Supplementary Fig. 1a). The gene discussed is HNF1B; the disease is posterior cortical atrophy.